1,110 results on '"Takehara, Kazuhiko"'
Search Results
52. Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports
53. Diagnosing Puffy Fingers in the Rheumatic Patient
54. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein
55. Antiphospholipid antibodies in patients with autoimmune blistering disease
56. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma
57. Anti-DNA topoisomerase II α autoantibodies in Japanese patients with systemic sclerosis
58. Augmented production of transforming growth factor-β by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
59. A case of anti‐OJ antibody‐positive polymyositis with marked muscle involvement and interstitial lung disease
60. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
61. The Frequency of Type 2 CD8+ T Cells Is Increased in Peripheral Blood from Patients with Psoriasis Vulgaris
62. FTY720 Ameliorates Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Promoting Expansion of Splenic Regulatory Cells and Inhibiting Immune Cell Infiltration Into Skin
63. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis
64. Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis
65. PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population
66. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort
67. Two cases of livedo vasculopathy with non-criteria antiphospholipid antibodies
68. Skin sclerosis as a manifestation of POEMS syndrome
69. Potential roles of interleukin-17A in the development of skin fibrosis in mice
70. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis
71. Esophageal hypomotility in systemie sclerosis: Close relationship with pulmonary involvement
72. Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis
73. Association of UBE2L3 polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population
74. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
75. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins
76. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study
77. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
78. Association between nail-fold capillary findings and disease activity in dermatomyositis
79. Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis: A Multicenter Cross-sectional Study
80. Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody
81. Characteristics of Japanese patients with eosinophilic fasciitis: A brief multicenter study
82. Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis
83. Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: Results from a multicentre prospective cohort in Japan
84. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study
85. A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor
86. Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial
87. Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study
88. Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis
89. Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis
90. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis: 90074
91. Adipose‐derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models
92. Stevens–Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor
93. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway
94. Intractable genital ulcers from herpes simplex virus reactivation in drug-induced hypersensitivity syndrome caused by allopurinol
95. Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis
96. Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease
97. Chromoblastomycosis caused by Phialophora verrucosa on the hand
98. Association of the FAM167A–BLK region with systemic sclerosis
99. Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis
100. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.